BioPharmaceutical Emerging Best Practices Association

2026 Asia Bioassay Conference

Incheon, South Korea  |  November 4-6, 2026

Registration

Registration is not yet open for our 2026 Asia Bioassay Conference. Check back soon!

3-Day Event

(In-Person Only)
November 4-6, 2026

2-Day Event

(In-Person or Virtual)
November 5-6, 2026

Quick Links

November, 2026
Incheon, South Korea

Hybrid Conference

Deadlines

Abstract Submission: March 6, 2026
Poster Submission: Oct. 14, 2026
Next Price Increase: TBA
Registration Closes:
In-person closes Oct. 23, 2026
Virtual closes Oct. 30, 2026

Draft Agenda

Our 2026 Asia Bioassay Conference agenda is coming soon! Abstracts are due by March 6th to be considered for a podium talk. Check the agenda for updates as we finalize our schedule.

Note: The official language of the conference is English. No simultaneous translation will be provided.

Suggested Topics:

  • Handling legal and biological aspects for cell lines of cell based assays
  • Product specific potency assays – for classic, complex and novel products
  • Validation of Potency Assays
  • Regulatory Frameworks for Potency BioAssays: Implementation of Regulatory Guidances in Potency BioAssays, Expectations for bioassay during the licensure process,
  • Developing and Maintaining in-house Reference Materials for Potency Assays
  • The ins and outs of assessing equivalence for BioSimilar Products
  • AI and Automation in Potency Labs
  • What are the QA requirements for BioAssays?
  • Evoloving Statistical Tools for Relative Potency Assays: DOE, Bayesian Statistics, Assessing Dose Response Curve Similarity, Use of Outlier Analysis
  • BioAssays for Complex Proteome and Cell-based Products
  • Developing and Maintaining Critical Reagents for Potency BioAssays
  • Not all potency bioassays are relative potency assays, discussions of what these methods are and how they are developed.
  • Stability Indicating Properties of Potency Assays

Don’t see your topic listed above? Submit anyway! Those presentations often end up being our most loved!

Participating Companies:

  • List Coming Soon

Hotel Information

A room block is being prepared for the 2026 Hybrid Asia Bioassay Conference. Check back for updates!

2026 Asia Bioassay Exhibitors

2026 Planning Committee

Gaurav Agrawal
Eurofins

Frank Fan
Promega Corporation

Chaohong (Mary) Hu
Independent Consultant

Hoosung Hwang
BioAnalytix Lab

Xu-Rong Jiang
Bristol Myers Squibb

Jun Kim
BioAnalytix Lab

Laureen Little

Laureen Little
BEBPA

Jun Park
Korea Health Industry Development Institute

SungAe Park
Independent Consultant

Ayumi Takayanagi
Chugai Pharmaceutical

Andrew Thomson
GreyRigge Associates

Yukina Umemoto
Chugai Pharmaceutical